Laura Foj

1.1k total citations
21 papers, 843 citations indexed

About

Laura Foj is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Laura Foj has authored 21 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Laura Foj's work include Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (10 papers) and Cancer, Lipids, and Metabolism (4 papers). Laura Foj is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (10 papers) and Cancer, Lipids, and Metabolism (4 papers). Laura Foj collaborates with scholars based in Spain and United States. Laura Foj's co-authors include Xavier Filella, Rafael Molina, Josep M. Augé, F. Ferrer, Núria Giménez, José Miguel Escudero Fernández, Jaume Pahisa, Aureli Torné, José Maria Augé and J. A. Lejárcegui and has published in prestigious journals such as International Journal of Molecular Sciences, Clinica Chimica Acta and Osteoporosis International.

In The Last Decade

Laura Foj

19 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Foj Spain 14 407 379 323 109 80 21 843
Huimin Wang China 15 480 1.2× 301 0.8× 56 0.2× 155 1.4× 29 0.4× 34 745
Florence Mishellany France 17 195 0.5× 217 0.6× 105 0.3× 74 0.7× 22 0.3× 37 811
Yunsong Li China 15 561 1.4× 148 0.4× 145 0.4× 27 0.2× 71 0.9× 50 905
Bilan Li China 14 295 0.7× 111 0.3× 236 0.7× 56 0.5× 113 1.4× 20 613
Nobuhisa Yoshikawa Japan 18 266 0.7× 145 0.4× 88 0.3× 384 3.5× 156 1.9× 91 980
Xigan He China 12 459 1.1× 327 0.9× 114 0.4× 15 0.1× 106 1.3× 28 706
Jianguo Hou China 16 495 1.2× 356 0.9× 238 0.7× 13 0.1× 139 1.7× 29 809
Richard Gunu United Kingdom 9 163 0.4× 141 0.4× 56 0.2× 94 0.9× 80 1.0× 11 450
Evelina La Civita Italy 15 173 0.4× 148 0.4× 243 0.8× 10 0.1× 133 1.7× 39 574
Shuqin Dai China 15 239 0.6× 170 0.4× 138 0.4× 24 0.2× 96 1.2× 40 575

Countries citing papers authored by Laura Foj

Since Specialization
Citations

This map shows the geographic impact of Laura Foj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Foj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Foj more than expected).

Fields of papers citing papers by Laura Foj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Foj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Foj. The network helps show where Laura Foj may publish in the future.

Co-authorship network of co-authors of Laura Foj

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Foj. A scholar is included among the top collaborators of Laura Foj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Foj. Laura Foj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mademont‐Soler, Irene, Laura Foj, Mar Xunclà, et al.. (2025). Incidental Findings Identified by Prenatal Microarray Analysis and Consensus Reporting Criteria of the Catalan Public Health Network XIGENICS. Prenatal Diagnosis. 45(3). 326–347.
2.
Filella, Xavier, et al.. (2022). Value of PHI and PHID in the detection of intermediate- and high-risk prostate cancer. Clinica Chimica Acta. 531. 277–282. 10 indexed citations
3.
Foj, Laura & Xavier Filella. (2019). Development and internal validation of a novel PHI-nomogram to identify aggressive prostate cancer. Clinica Chimica Acta. 501. 174–178. 12 indexed citations
4.
Filella, Xavier, et al.. (2018). Emerging biomarkers in the diagnosis of prostate cancer. Pharmacogenomics and Personalized Medicine. Volume 11. 83–94. 88 indexed citations
5.
Foj, Laura & Xavier Filella. (2018). Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis. Pathology & Oncology Research. 25(4). 1445–1456. 19 indexed citations
6.
Filella, Xavier & Laura Foj. (2018). Novel Biomarkers for Prostate Cancer Detection and Prognosis. Advances in experimental medicine and biology. 1095. 15–39. 21 indexed citations
7.
Peris, Pilar, Xavier Filella, Ana Monegal, et al.. (2017). Concordance between direct and indirect measurements of free 25-OH vitamin D. Clinica Chimica Acta. 475. 169–171. 9 indexed citations
8.
Peris, Pilar, Xavier Filella, Ana Monegal, et al.. (2017). Comparison of total, free and bioavailable 25-OH vitamin D determinations to evaluate its biological activity in healthy adults: the LabOscat study. Osteoporosis International. 28(8). 2457–2464. 20 indexed citations
9.
Parra‐Robert, Marina, Laura Foj, & Xavier Filella. (2016). Automated measurement of 25-OH Vitamin D on the LUMIPULSE®G1200: analytical verification and method comparison. British Journal of Biomedical Science. 73(3). 104–109. 2 indexed citations
10.
Filella, Xavier & Laura Foj. (2016). miRNAs as novel biomarkers in the management of prostate cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 55(5). 715–736. 91 indexed citations
11.
Filella, Xavier & Laura Foj. (2016). Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers. International Journal of Molecular Sciences. 17(11). 1784–1784. 96 indexed citations
12.
Filella, Xavier & Laura Foj. (2015). Emerging biomarkers in the detection and prognosis of prostate cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 53(7). 963–73. 34 indexed citations
13.
Foj, Laura, Montserrat Milà, Lourdes Mengual, et al.. (2014). Real-time PCR PCA3 assay is a useful test measured in urine to improve prostate cancer detection. Clinica Chimica Acta. 435. 53–58. 12 indexed citations
14.
Filella, Xavier, Laura Foj, J Alcover, et al.. (2014). The influence of prostate volume in prostate health index performance in patients with total PSA lower than 10μg/L. Clinica Chimica Acta. 436. 303–307. 30 indexed citations
15.
Filella, Xavier, Laura Foj, Josep M. Augé, Rafael Molina, & J Alcover. (2014). Clinical utility of %p2PSA and prostate health index in the detection of prostate cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 52(9). 1347–55. 35 indexed citations
16.
Foj, Laura, Xavier Filella, J Alcover, et al.. (2013). Variability of assay methods for total and free PSA after WHO standardization. Tumor Biology. 35(3). 1867–1873. 18 indexed citations
17.
Filella, Xavier, Laura Foj, Montserrat Milà, et al.. (2013). PCA3 in the detection and management of early prostate cancer. Tumor Biology. 34(3). 1337–1347. 45 indexed citations
18.
Filella, Xavier, Laura Foj, J Alcover, et al.. (2013). ProPSA, un nuevo biomarcador para la detección y el manejo del cáncer de próstata. Revista del Laboratorio Clínico. 6(2). 75–81.
19.
Molina, Rafael, José Miguel Escudero Fernández, José Maria Augé, et al.. (2011). HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases. Tumor Biology. 32(6). 1087–1095. 133 indexed citations
20.
Casals, Gregori, Laura Foj, & María J. Martínez de Osaba. (2011). Day-to-day variation of late-night salivary cortisol in healthy voluntaries. Clinical Biochemistry. 44(8-9). 665–668. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huimin Wang Breakdown of academic impact, for papers by Florence Mishellany Breakdown of academic impact, for papers by Yunsong Li Breakdown of academic impact, for papers by Bilan Li Breakdown of academic impact, for papers by Nobuhisa Yoshikawa Breakdown of academic impact, for papers by Xigan He Breakdown of academic impact, for papers by Jianguo Hou Breakdown of academic impact, for papers by Richard Gunu Breakdown of academic impact, for papers by Evelina La Civita Breakdown of academic impact, for papers by Shuqin Dai
Rankless by CCL
2026